Antin Infrastructure Partners SAS (EPA:ANTIN)
France · Delayed Price · Currency is EUR 11.60
+0.04 (0.35%)
Aug 13, 2025, 2:41 PM CET
Intra-Cellular Therapies Market Cap
EPA:ANTIN has a market cap or net worth of €2.07 billion as of August 13, 2025. Its market cap has decreased by -3.60% in one year.
Market Cap
2.07B
Enterprise Value
1.75B
Revenue
318.37M
Ranking
n/a
PE Ratio
15.65
Stock Price
$11.60
Market Cap Chart
Since September 24, 2021, EPA:ANTIN's market cap has decreased from 4.77B to 2.07B, a decrease of -56.73%. That is a compound annual growth rate of -19.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.07B | 4.62% |
| Dec 31, 2024 | 1.97B | -20.03% |
| Dec 29, 2023 | 2.47B | -30.33% |
| Dec 30, 2022 | 3.54B | -41.17% |
| Dec 31, 2021 | 6.02B | 26.20% |
| Sep 24, 2021 | 4.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BNP Paribas | 91.10B |
| AXA SA | 90.07B |
| Crédit Agricole | 51.18B |
| Société Générale Société anonyme | 45.19B |
| Euronext | 14.11B |
| Amundi | 13.41B |
| Edenred SE | 6.23B |
| Compagnie du Cambodge | 6.01B |